Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Lipid Metabolism, Inborn Error

fluorodeoxyglucose f18 has been researched along with Lipid Metabolism, Inborn Error in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, X; Cui, Y; Fu, Z1
McNamee, A; O'Gorman, P; Robertson, T; Sounness, B1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and Lipid Metabolism, Inborn Error

ArticleYear
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:12

    Topics: Fluorodeoxyglucose F18; Humans; Lipid Metabolism, Inborn Errors; Muscular Dystrophies

2020
FDG PET/CT of Metabolic Myopathy With Posttreatment Follow-up.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:9

    Topics: Adult; Fatty Acids; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lipid Metabolism, Inborn Errors; Muscular Dystrophies; Oxidation-Reduction; Paraspinal Muscles; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2018